J. Jack Lee

90.8k total citations · 10 hit papers
1.1k papers, 50.3k citations indexed

About

J. Jack Lee is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Jack Lee has authored 1.1k papers receiving a total of 50.3k indexed citations (citations by other indexed papers that have themselves been cited), including 295 papers in Molecular Biology, 246 papers in Oncology and 228 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Jack Lee's work include Lung Cancer Treatments and Mutations (118 papers), Cancer Genomics and Diagnostics (85 papers) and Statistical Methods in Clinical Trials (74 papers). J. Jack Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (118 papers), Cancer Genomics and Diagnostics (85 papers) and Statistical Methods in Clinical Trials (74 papers). J. Jack Lee collaborates with scholars based in United States, Canada and United Kingdom. J. Jack Lee's co-authors include Scott M. Lippman, Waun Ki Hong, Adel K. El‐Naggar, Ignacio I. Wistuba, Diane D. Liu, Reuben Lotan, Razelle Kurzrock, Raghu Kalluri, Valerie S. LeBleu and Sujuan Yang and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

J. Jack Lee

1.1k papers receiving 48.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

2017 2.0k citations J. Jack Lee et al. profile →
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

2002 1.1k citations J. Jack Lee et al. profile →
Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients

1999 865 citations J. Jack Lee et al. profile →
Targeting the tumour vasculature: insights from physiological angiogenesis

2010 620 citations J. Jack Lee et al. profile →
Dose Escalation Methods in Phase I Cancer Clinical Trials

2009 568 citations J. Jack Lee et al. profile →
bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

1995 520 citations J. Jack Lee et al. profile →
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

2019 429 citations Vincent A. Miller, J. Jack Lee et al. profile →
IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves

2021 395 citations J. Jack Lee et al. profile →
Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer

2019 249 citations J. Jack Lee et al. profile →
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

2018 214 citations J. Jack Lee, John V. Heymach et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Jack Lee United States	111	17.2k	14.9k	11.4k	7.5k	6.5k	1.1k	50.3k
Joannie Lortet‐Tieulent France	32	12.8k 0.7×	13.4k 0.9×	9.2k 0.8×	9.0k 1.2×	6.6k 1.0×	47	37.7k
Paola Pisani Italy	43	10.4k 0.6×	11.8k 0.8×	6.7k 0.6×	5.9k 0.8×	6.9k 1.1×	131	34.5k
Peter Boyle Italy	100	8.1k 0.5×	13.9k 0.9×	8.6k 0.8×	5.0k 0.7×	5.6k 0.9×	635	43.8k
M. J. Thun United States	25	10.1k 0.6×	13.2k 0.9×	8.5k 0.7×	5.3k 0.7×	5.1k 0.8×	39	32.8k
Ian F. Tannock Canada	95	9.6k 0.6×	16.6k 1.1×	16.7k 1.5×	8.1k 1.1×	5.5k 0.9×	426	44.1k
Bernard Rosner United States	146	11.6k 0.7×	15.0k 1.0×	6.9k 0.6×	5.6k 0.7×	7.0k 1.1×	1.1k	97.0k
Hermann Brenner Germany	112	11.2k 0.7×	23.9k 1.6×	12.3k 1.1×	6.1k 0.8×	12.2k 1.9×	1.5k	64.7k
Wanqing Chen China	62	11.2k 0.7×	10.8k 0.7×	7.9k 0.7×	8.1k 1.1×	5.5k 0.9×	301	31.1k
Jiaquan Xu China	49	10.4k 0.6×	10.7k 0.7×	8.3k 0.7×	4.9k 0.7×	5.0k 0.8×	129	35.2k
Yu Shyr United States	91	11.8k 0.7×	10.0k 0.7×	6.5k 0.6×	6.1k 0.8×	4.7k 0.7×	542	33.2k

Countries citing papers authored by J. Jack Lee

Since Specialization

Citations

This map shows the geographic impact of J. Jack Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jack Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jack Lee more than expected).

Fields of papers citing papers by J. Jack Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jack Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jack Lee. The network helps show where J. Jack Lee may publish in the future.

Co-authorship network of co-authors of J. Jack Lee

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jack Lee. A scholar is included among the top collaborators of J. Jack Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jack Lee. J. Jack Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parra, Edwin R., Carmen Behrens, Jaime Rodriguez‐Canales, et al.. (2016). Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients. Clinical Cancer Research. 22(24). 6278–6289. 103 indexed citations

Tang, Chad, Kenneth R. Hess, Suzanne E. Davis, et al.. (2016). Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual. Clinical Cancer Research. 23(6). 1407–1413. 9 indexed citations

Wheler, Jennifer J., Filip Jankú, Aung Naing, et al.. (2016). TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics. Molecular Cancer Therapeutics. 15(10). 2475–2485. 73 indexed citations

Kabbout, Mohamed, Melinda Garcia, Junya Fujimoto, et al.. (2013). ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(13). 3383–3395. 116 indexed citations

William, William N., Ying Liu, Jie Ma, et al.. (2013). Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease. Molecular Cancer Therapeutics. 12(6). 1112–1121. 27 indexed citations

Gold, Kathryn A., Edward S. Kim, Diane D. Liu, et al.. (2013). Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy. Clinical Cancer Research. 20(7). 1946–1954. 27 indexed citations

Yao, James C., Funda Meric‐Bernstam, J. Jack Lee, & Sabine Eckhardt. (2013). Accelerated Approval and Breakthrough Therapy Designation: Oncology Drug Development on Speed?. Clinical Cancer Research. 19(16). 4305–4308. 8 indexed citations

Sadanandom, Ari, et al.. (2012). The ubiquitin–proteasome system: central modifier of plant signalling. New Phytologist. 196(1). 13–28. 322 indexed citations

Kadara, Humam, Li Shen, Junya Fujimoto, et al.. (2012). Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling. Cancer Prevention Research. 6(1). 8–17. 26 indexed citations

10.

Tang, Ximing, Humam Kadara, Carmen Behrens, et al.. (2011). Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis. Clinical Cancer Research. 17(8). 2434–2443. 59 indexed citations

11.

Kim, Woo‐Young, Mi-Jung Kim, Hojin Moon, et al.. (2011). Differential Impacts of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) in Epithelial IGF-Induced Lung Cancer Development. Endocrinology. 152(6). 2164–2173. 19 indexed citations

12.

Saintigny, Pierre, Li Zhang, You-Hong Fan, et al.. (2011). Gene Expression Profiling Predicts the Development of Oral Cancer. Cancer Prevention Research. 4(2). 218–229. 109 indexed citations

13.

Kim, Edward S., Waun Ki Hong, J. Jack Lee, et al.. (2010). Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers. Cancer Prevention Research. 3(2). 148–159. 39 indexed citations

14.

Saintigny, Pierre, Sufi M. Thomas, Adel K. El‐Naggar, et al.. (2010). Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer. Cancer Prevention Research. 3(7). 800–809. 88 indexed citations

15.

Kadara, Humam, Carmen Behrens, Ping Yuan, et al.. (2010). A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis. Clinical Cancer Research. 17(6). 1490–1501. 68 indexed citations

16.

William, William N., J. Jack Lee, Scott M. Lippman, et al.. (2009). High-Dose Fenretinide in Oral Leukoplakia. Cancer Prevention Research. 2(1). 22–26. 33 indexed citations

17.

Kim, Woo-Young, Quanri Jin, Edward S. Kim, et al.. (2009). Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development. Cancer Research. 69(18). 7439–7448. 60 indexed citations

18.

Tsao, Anne S., Diane Liu, Jack W. Martin, et al.. (2009). Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions. Cancer Prevention Research. 2(11). 931–941. 182 indexed citations

19.

Zhang, Li, J. Jack Lee, Hongli Tang, et al.. (2008). Impact of Smoking Cessation on Global Gene Expression in the Bronchial Epithelium of Chronic Smokers. Cancer Prevention Research. 1(2). 112–118. 57 indexed citations

20.

Bhutani, Manisha, Ashutosh Pathak, You-Hong Fan, et al.. (2008). Oral Epithelium as a Surrogate Tissue for Assessing Smoking-Induced Molecular Alterations in the Lungs. Cancer Prevention Research. 1(1). 39–44. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact